A new preprint study by the Cleveland Clinic found people previously infected with SARS-CoV-2 were less likely to be reinfected than fully vaccinated individuals who never had the virus [.]
UC San Diego School of Medicine researchers discovered gene expression patterns associated with pandemic viral infections, providing a map to help define patients immune responses, measure disease severity, predict outcomes and test therapies for current and future pandemics.
Lukas Schulze/Getty Images
toggle caption Lukas Schulze/Getty Images
A woman receives the Johnson & Johnson COVID-19 at a drive-in vaccination event last week in Meerbusch, Germany. Lukas Schulze/Getty Images
The emergence of new and more infectious variants of the coronavirus has raised a troubling question: Will the current crop of COVID-19 vaccine prevent these variants from causing disease?
Nature suggests the answer is yes.
The research was fairly straightforward. Scientists took blood from volunteers who had received the Johnson & Johnson COVID-19 vaccine and looked at the levels of neutralizing antibodies, the kind that prevent a virus from entering cells.
New Evidence Suggests COVID-19 Vaccines Remain Effective Against Variants
Update RequiredTo play audio, update browser or Flash plugin.
A woman receives the Johnson & Johnson COVID-19 at a drive-in vaccination event last week in Meerbusch, Germany.
Lukas Schulze / Getty Images
The emergence of new and more infectious variants of the coronavirus has raised a troubling question: Will the current crop of COVID-19 vaccine prevent these variants from causing disease?
Nature suggests the answer is yes.
The research was fairly straightforward. Scientists took blood from volunteers who had received the Johnson & Johnson COVID-19 vaccine and looked at the levels of neutralizing antibodies, the kind that prevent a virus from entering cells.
As the United States edges closer to President Joe Biden’s goal of a 70 percent inoculation rate, several people are starting to wonder how long their protection will last. Numerous scientists surmise that the Moderna, Pfizer-BioNTech, and Johnson & Johnson vaccines authorized in the US will last at least a year, but are unsure.